Inappropriate use of protein C, protein S, and antithrombin testing for hereditary thrombophilia screening: An experience from a large university hospital

International Journal of Laboratory Hematology

Volumn 33, Issue 6, 2011, Pages 593-600

  Tientadakul, P ^a   Chinthammitr, Y ^a   Sanpakit, K ^a   Wongwanit, C ^a   Nilanont, Y ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antithrombin; Protein C; Protein S; Thrombophilia; Utilization

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ASPARAGINASE; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; CLINICAL EDUCATION; CONFIDENCE INTERVAL; ENZYME ASSAY; FEMALE; HUMAN; KAPPA STATISTICS; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS SCREENING; MIDDLE AGED; PROTEIN C; PROTEIN S; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; THAILAND; THROMBOPHILIA; YOUNG ADULT;

EID: 80054686265     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01332.x     Document Type: Article

References (37)

1. Adcock D.M., Fink L. & Marlar R.A. (1997) A laboratory approach to the evaluation of hereditary hypercoagulability. American Journal of Clinical Pathology 108, 434-449.
2. Andrew M. (1995) Developmental hemostasis: relevance to hemostatic problems during childhood. Seminars in Thrombosis and Hemostasis 21, 341-356.
3. Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F. & Mitchell L. (1992) Maturation of the hemostatic system during childhood. Blood 80, 1998-2005.
4. Angchaisuksiri P., Atichartakarn V., Aryurachai K., Archararit N., Rachakom B., Atamasirikul K. & Tiraganjana A. (2007) Risk factors of venous thromboembolism in thai patients. International Journal of Hematology 86, 397-402.
5. Anonymous (2001) Investigation and management of heritable thrombophilia. British Journal of Haematology 114, 512-528.
6. Appel I.M., Hop W.C., van Kessel-Bakvis C., Stigter R. & Pieters R. (2008) l-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thrombosis and Haemostasis 100, 330-337.
7. Baglin T., Gray E., Greaves M., Hunt B.J., Keeling D., Machin S., Mackie I., Makris M., Nokes T., Perry D., Tait R.C., Walker I. & Watson H. (2010) Clinical guidelines for testing for heritable thrombophilia. British Journal of Haematology 149, 209-220.
8. Bauer K.A. (2001) The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Annals of Internal Medicine 135, 367-373.
9. Brenner B.R., Nowak-Gottl U., Kosch A., Manco-Johnson M. & Laposata M. (2002) Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Archives of Pathology and Laboratory Medicine 126, 1296-1303.
10. Buchanan G.S., Rodgers G.M. & Ware Branch D. (2003) The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation. Best Practice and Research. Clinical Obstetrics and Gynaecology 17, 397-411.
11. Bushnell C.D. & Goldstein L.B. (2002) Physician knowledge and practices in the evaluation of coagulopathies in stroke patients. Stroke 33, 948-953.
12. Carraro P. (2003) Guidelines for the laboratory investigation of inherited thrombophilias. Recommendations for the first level clinical laboratories. Clinical Chemistry and Laboratory Medicine 41, 382-391.
13. Carraro P. & Simioni P. (2003) Appropriateness of choice and interpretation of tests for thrombophilic defects: a practical experience. Clinica Chimica Acta 333, 191-193.
14. Foy P. & Moll S. (2009) Thrombophilia: 2009 update. Current Treatment Options in Cardiovascular Medicine 11, 114-128.
15. Goodwin A.J., Rosendaal F.R., Kottke-Marchant K. & Bovill E.G. (2002) A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Archives of Pathology and Laboratory Medicine 126, 1349-1366.
16. Heit J.A. (2007) Thrombophilia: common questions on laboratory assessment and management. Hematology 2007, 127-135.
17. Jackson B.R., Holmes K., Phansalkar A. & Rodgers G.M. (2008) Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory. BMC Clinical Pathology 8, 3.
18. Karpatkin S., Nardi M. & Green D. (2002) Platelet and coagulation defects associated with HIV-1-infection. Thrombosis and Haemostasis 88, 389-401.
19. Kearon C., Kahn S.R., Agnelli G., Goldhaber S., Raskob G.E. & Comerota A.J. (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133, 454S-545S.
20. Kottke-Marchant K. & Comp P. (2002) Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Archives of Pathology and Laboratory Medicine 126, 1337-1348.
21. Kovacs M.J., Kovacs J., Anderson J., Rodger M.A., Mackinnon K. & Wells P.S. (2006) Protein C and protein S levels can be accurately determined within 24hours of diagnosis of acute venous thromboembolism. Clinical and Laboratory Haematology 28, 9-13.
22. Lijfering W.M., Sprenger H.G., Georg R.R., van der Meulen P.A. & van der Meer J. (2008) Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clinical Chemistry 54, 1226-1233.
23. Lippi G., Franchini M., Montagnana M. & Guidi G.C. (2007) Coagulation testing in pediatric patients: the young are not just miniature adults. Seminars in Thrombosis and Hemostasis 33, 816-820.
24. Mahmoodi B.K., Brouwer J.L., Veeger N.J. & van der Meer J. (2008) Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 118, 1659-1667.
25. McKenzie S.B., Clare C.N., Smith L.A. & Sang J.E. (2000) Laboratory test utilization in the diagnosis of hypercoagulability. Clinical Laboratory Science 13, 215-221.
26. Merriman L. & Greaves M. (2006) Testing for thrombophilia: an evidence-based approach. Postgraduate Medical Journal 82, 699-704.
27. Middeldorp S. & van Hylckama Vlieg A. (2008) Does thrombophilia testing help in the clinical management of patients? British Journal of Haematology 143, 321-335.
28. Moster M.L. (2003) Coagulopathies and arterial stroke. Journal of Neuro-Ophthalmology 23, 63-71.
29. Olson J.D. (2002) College of American Pathologists Consensus Conference XXXVI: diagnostic Issues in Thrombophilia. Archives of Pathology and Laboratory Medicine 126, 1277-1433.
30. Pengo V., Tripodi A., Reber G., Rand J.H., Ortel T.L., Galli M. & de Groot P.G. (2009) Update of the guidelines for lupus anticoagulant detection. Journal of Thrombosis and Haemostasis 7, 1737-1740.
31. Revel-Vilk S. & Massicotte P. (2003) Thromboembolic diseases of childhood. Blood Reviews 17, 1-6.
32. Somma J., Sussman I.I. & Rand J.H. (2006) An evaluation of thrombophilia screening in an urban tertiary care medical center: a "real world" experience. American Journal of Clinical Pathology 126, 120-127.
33. Tait R.C., Walker I.D., Islam S.I., Mitchell R., Conkie J.A., McCall F. & Davidson J.F. (1991) Age related changes in protein C activity in healthy adult males. Thrombosis and Haemostasis 65, 326-327.
34. Tientadakul P., Wongtiraporn W., Luenee P., Theansun W. & Opartkiatikul N. (2001) Evaluation of home-made ELISA's for protein C and protein S antigenic assays. Siriraj Hospital Gazette, Vol. 53, 523-529.
35. Tormene D., Pagnan A., Prandoni P. & Simioni P. (2004) Screening for thrombophilia in children: a puzzling decision with unclear implications. Journal of Thrombosis and Haemostasis 2, 1193-1194.
36. Tripodi A. (2005) A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia. Seminars in Thrombosis and Hemostasis 31, 25-32.
37. White R.H. & Gosselin R.C. (2009) Testing for thrombophilia: pitfalls, limitations, and marginal impact on treatment duration recommendations. Mount Sinai Journal of Medicine 76, 303-313.